ArticlePloS one2016

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Kentaro Minagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.